Stay updated on Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer's site revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of a study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide alert announces changes to NIH websites and says that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now shows a 403 Forbidden error for the entry, indicating access to the record is blocked. This reflects a site-access issue rather than a substantive update to the study data.SummaryDifference18%

- Check70 days agoChange DetectedThe page now displays the revision label as v3.6.6, replacing the previous v3.6.5. This is a minor site maintenance update that does not modify the study content or its presentation.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.